(5 intermediate revisions by 3 users not shown) | |||
Line 91: | Line 91: | ||
width: auto; | width: auto; | ||
} | } | ||
− | --></style> | + | --> |
+ | #underline{ border-bottom: solid 1px #ff0000; } | ||
+ | </style> | ||
</head> | </head> | ||
<body> | <body> | ||
Line 101: | Line 103: | ||
<div id="prhl" class="container"> | <div id="prhl" class="container"> | ||
<div id="prhl_header" class="container_header"> | <div id="prhl_header" class="container_header"> | ||
− | <h1><span>Prhl(NM)-<span style="font-style: italic;">rbs-gfp</span>: <a href="http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</a></span></h1> | + | <h1><span class="underline">Prhl(NM)-<span style="font-style: italic;">rbs-gfp</span>: <a href="http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</a></span></h1> |
</div><!-- /prhl_header --> | </div><!-- /prhl_header --> | ||
Line 107: | Line 109: | ||
<h2 align="center"><a href="http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</a> meets the Silver Medal criteria!</h2> | <h2 align="center"><a href="http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</a> meets the Silver Medal criteria!</h2> | ||
− | <p class="normal_text">We simulated our final genetic circuits and found that the circuits | + | <p class="normal_text">We simulated our final genetic circuits and found that the circuits would not work, because Prhl (<a href="http://parts.igem.org/Part:BBa_I14017">BBa_I14017</a>) strength was too weak. (see <a href="https://2016.igem.org/Team:Tokyo_Tech/Model"> the Model page </a> and <a href="https://2016.igem.org/Team:Tokyo_Tech/AHL_Assay/Only_Assay">the AHL only assay page</a>). We therefore considered using the improved Prhl (<a href="http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a>, <a href="http://parts.igem.org/Part:BBa_K1529310">BBa_K1529310</a>) established by iGEM 2014 team Tokyo_Tech, but we noticed that they were inappropriate for two reasons (see our work <a href="https://2016.igem.org/Team:Tokyo_Tech/AHL_Assay/Rhl_System_Assay">Rhl system assay</a>). Then, we decided to further improve this Prhl and obtain our original improved Prhl (included in <a href="http://parts.igem.org/BBa_K1949060">BBa_K1949060</a>) that suited our goal. |
− | Our purpose is to create strong Prhl for our final genetic circuits. | + | Our purpose is to create a strong Prhl for our final genetic circuits. |
This experiment consists of the three parts below.</p> | This experiment consists of the three parts below.</p> | ||
Line 114: | Line 116: | ||
<ol type="I"> | <ol type="I"> | ||
− | <li><p class="normal_text"> | + | <li><p class="normal_text">Improvement of iGEM 2014 team Tokyo_Tech's Prhl(<a href="http://parts.igem.org/BBa_K1529300">BBa_K1529300</a>, <a href="http://parts.igem.org/BBa_K1529310">BBa_K1529310</a>) and characterize RhlR assay (Fig.4-3-1)</p></li> |
<div align="center"><img src="https://static.igem.org/mediawiki/2016/c/cc/T--Tokyo_tech--Fig.4_1_1.png" height="300"><br></div> | <div align="center"><img src="https://static.igem.org/mediawiki/2016/c/cc/T--Tokyo_tech--Fig.4_1_1.png" height="300"><br></div> | ||
− | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-1</span> | + | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-1 Effect of RhlR by tagging LVA <br>and The colonies of transformants with a rhlR (left) or a rhlR - LVA (right)</span> |
<li><p class="normal_text">Improvement of the wild type Prhl(<a href="http://parts.igem.org/BBa_I14017">BBa_I14017</a>) (Fig.4-3-2)</p></li> | <li><p class="normal_text">Improvement of the wild type Prhl(<a href="http://parts.igem.org/BBa_I14017">BBa_I14017</a>) (Fig.4-3-2)</p></li> | ||
<div align="center"><img src="https://static.igem.org/mediawiki/2016/a/a7/T--Tokyo_tech--Fig.4_1_2.png" height="300"><br></div> | <div align="center"><img src="https://static.igem.org/mediawiki/2016/a/a7/T--Tokyo_tech--Fig.4_1_2.png" height="300"><br></div> | ||
− | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-2</span> | + | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-2 RFU of GFP / Turbidity of imoroved Prhl mutants</span> |
− | <li><p class="normal_text">Comparison of | + | <li><p class="normal_text">Comparison of iGEM 2014 team Tokyo_Tech's Prhl to our original improved Prhl (included in <a href="http://parts.igem.org/BBa_K1949060">BBa_K1949060</a>) (Fig.4-3-3)</p></li> |
<div align="center"><img src="https://static.igem.org/mediawiki/2016/b/b1/T--Tokyo_tech--Fig.4_1_3.png" height="300"><br></div> | <div align="center"><img src="https://static.igem.org/mediawiki/2016/b/b1/T--Tokyo_tech--Fig.4_1_3.png" height="300"><br></div> | ||
− | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-3</span> | + | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-3 Comparison of Prhl(NM) by Prhl(LR)</span> |
</ol> | </ol> | ||
Line 133: | Line 135: | ||
<div id="other_composite_parts" class="container"> | <div id="other_composite_parts" class="container"> | ||
<div id="other_composite_parts_header" class="container_header"> | <div id="other_composite_parts_header" class="container_header"> | ||
− | <h1><span>Tokyo Tech 2016 iGEM Team: The Others Composite Parts</span></h1> | + | <h1><span style="border-bottom: solid 2px;">Tokyo Tech 2016 iGEM Team: The Others Composite Parts</span></h1> |
</div><!-- /other_composite_parts_header --> | </div><!-- /other_composite_parts_header --> | ||
Line 225: | Line 227: | ||
<div id="yafon_parts" class="container"> | <div id="yafon_parts" class="container"> | ||
<div id="yafon_parts_header" class="container_header"> | <div id="yafon_parts_header" class="container_header"> | ||
− | < | + | <span style="border-bottom: solid 2px;"><h1><i>yafON</i> Composite Parts: <a href="http://parts.igem.org/Part:BBa_K1949032">BBa_K1949032</a> and <a href="http://parts.igem.org/Part:BBa_K1949033">BBa_K1949033</a></h1></span> |
</div><!-- /yafon_parts_header --> | </div><!-- /yafon_parts_header --> | ||
Line 238: | Line 240: | ||
<div align="center"><img src="https://static.igem.org/mediawiki/2016/f/f8/T--Tokyo_tech--Fig.4_2_4%282%29.png" height="250"><br></div> | <div align="center"><img src="https://static.igem.org/mediawiki/2016/f/f8/T--Tokyo_tech--Fig.4_2_4%282%29.png" height="250"><br></div> | ||
− | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-4</span></p></div> | + | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-4 Confirming YafO function as toxin on agar plates</span></p></div> |
Line 245: | Line 247: | ||
<div align="center"><img src="https://static.igem.org/mediawiki/2016/4/49/T--Tokyo_tech--Fig.4_2_4.png" height="300"><br></div> | <div align="center"><img src="https://static.igem.org/mediawiki/2016/4/49/T--Tokyo_tech--Fig.4_2_4.png" height="300"><br></div> | ||
− | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-5</span></p></div> | + | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-5 toxin-antitoxin assay</span></p></div> |
<p class="normal_text">For more information, read <a href="http://parts.igem.org/Part:BBa_K1949020">BBa_K1949020</a>, <a href="http://parts.igem.org/Part:BBa_K1949030">BBa_K1949030</a> !</p> | <p class="normal_text">For more information, read <a href="http://parts.igem.org/Part:BBa_K1949020">BBa_K1949020</a>, <a href="http://parts.igem.org/Part:BBa_K1949030">BBa_K1949030</a> !</p> | ||
Line 270: | Line 272: | ||
<div align="center"><img src="https://static.igem.org/mediawiki/2016/7/77/T--Tokyo_tech--Fig.4.png" height="200"><br></div> | <div align="center"><img src="https://static.igem.org/mediawiki/2016/7/77/T--Tokyo_tech--Fig.4.png" height="200"><br></div> | ||
− | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-5</span></p></div> | + | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-5 Time vs Turbidity (Stop & Go) and Time vs RFU of GFP (Stop & Go)</span></p> |
+ | <p class="normal_text">For more information, read <a href="http://parts.igem.org/Part:BBa_K1949100">BBa_K1949100</a>, <a href="http://parts.igem.org/Part:BBa_K1949101">BBa_K1949101</a> and <a href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</a>.</p> | ||
+ | |||
+ | </div> | ||
Line 280: | Line 285: | ||
<div align="center"><img src="https://static.igem.org/mediawiki/2016/b/b3/T--Tokyo_tech--Fig.4_3_6.png" height="300"><br></div> | <div align="center"><img src="https://static.igem.org/mediawiki/2016/b/b3/T--Tokyo_tech--Fig.4_3_6.png" height="300"><br></div> | ||
− | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-6</span></p></div> | + | <div align="center"><p class="caption" style="font-size: 16px; text-align: center;"><span style="font-weight: bold;">Fig. 4-3-6 Time vs Turbidity (Go &Stop) and Time vs RFU of GFP (Go &Stop)</span></p></div> |
− | <p class="normal_text">For more information, | + | <p class="normal_text">For more information, <a href="http://parts.igem.org/Part:BBa_K1949101">BBa_K1949101</a>, <a href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</a>, <a href="http://parts.igem.org/Part:BBa_K1949103">BBa_K1949103</a> and <a href="http://parts.igem.org/Part:BBa_K1949104">BBa_K1949104</a>.</p> |
</div><!-- /mazfe_parts_contents --> | </div><!-- /mazfe_parts_contents --> |
Latest revision as of 00:03, 20 October 2016
Composite Parts
Prhl(NM)-rbs-gfp: BBa_K1949060
BBa_K1949060 meets the Silver Medal criteria!
We simulated our final genetic circuits and found that the circuits would not work, because Prhl (BBa_I14017) strength was too weak. (see the Model page and the AHL only assay page). We therefore considered using the improved Prhl (BBa_K1529300, BBa_K1529310) established by iGEM 2014 team Tokyo_Tech, but we noticed that they were inappropriate for two reasons (see our work Rhl system assay). Then, we decided to further improve this Prhl and obtain our original improved Prhl (included in BBa_K1949060) that suited our goal. Our purpose is to create a strong Prhl for our final genetic circuits. This experiment consists of the three parts below.
For more information, read this page !
Improvement of iGEM 2014 team Tokyo_Tech's Prhl(BBa_K1529300, BBa_K1529310) and characterize RhlR assay (Fig.4-3-1)
Improvement of the wild type Prhl(BBa_I14017) (Fig.4-3-2)
Comparison of iGEM 2014 team Tokyo_Tech's Prhl to our original improved Prhl (included in BBa_K1949060) (Fig.4-3-3)
The past improved Prhl did not suit for our final circuits and we could construct the improved Prhl appropriate to our final circuits.
Tokyo Tech 2016 iGEM Team: The Others Composite Parts
Name | Type | Description | Design | Length(bp) |
---|---|---|---|---|
BBa_K1949001 | Measurement | Pcold-gfp | Yoshio Takata | 1033 |
BBa_K1949032 | Composite | PBAD-rbs-yafO | Yoshio Takata | 1638 |
BBa_K1949033 | Composite | PBAD-rbs-yafO-tt-Ptet-rbs-gfp | Yoshio Takata | 2580 |
BBa_K1949052 | Composite | PBAD-rbs-amiE | Yoshio Takata | 2712 |
BBa_K1949060 | Composite | Prhl(NM)-rbs-gfp | Yoshio Takata | 799 |
BBa_K1949100 | Composite | Plac-rbs-mazE | Yoshio Takata | 565 |
BBa_K1949101 | Composite | PBAD-rbs-mazF | Yoshio Takata | 1575 |
BBa_K1949102 | Composite | PBAD-rbs-mazF-tt-Ptet-rbs-gfp | Yoshio Takata | 2520 |
BBa_K1949103 | Composite | Ptet-rbs(BBa_B0034))-mazE | Yoshio Takata | 332 |
BBa_K1949104 | Composite | Ptet-rbs(BBa_J61117)-mazE | Yoshio Takata | 332 |
yafON Composite Parts: BBa_K1949032 and BBa_K1949033
BBa_K1949032 meets the Silver Medal criteria!
YafN is an antitoxin corresponding to toxin YafO, and YafN reverses inhibition of cell growth. yafN and yafO exist as an operon, and YafN also functions as a repressor in the operon. Therefore, yafNO operon’s translation is autoregulated by antitoxin YafN. When Lon protease senses environmental stresses such as DNA damage, the operon becomes active because of degradation of YafN by Lon protease.
Confirming Yafo Function as Toxin on Agar Medium
We first confirmed YafO function by observing formation of colonies on agar plate. This experiment was carried out using E. coli which inducible yafO expression by arabinose and E. coli without yafO gene. Construction of plasmids used in this experiment is shown in below. We inoculated four types of E. coli differently on agar plate with and without arabinose. As a result(Fig. 4-3-4), all types of E. coli were able to form colonies on agar plate with no arabinose, and colonies of E. coli (c) and (d) had RFU (Relative Fluorescence Units). On the other hand, E. coli (a) and (c) couldn’t form any colonies on agar plate containing arabinose. From these results, we confirmed that all types of E. coli in below functions as we expected.
Toxin-antitoxin assay
From previous experiment, we were able to confirm that YafO works as toxin. Next, we confirmed whether the cell growth reverses by antitoxin YafN after inhibition by YafO. Construction of plasmids used in this experiment is shown in below. We prepared E. coli which can induce expression of yafO by arabinose and YafN by lactose. As comparisons, we also carried out same experiment with E. coli containing no yafO gene, no yafN gene and none of them. As a result(Fig. 4-3-5), we couldn’t observe cell growth reversing after adding IPTG to induce expression of yafN, and their turbidity became constant as E. coli (c) containing no yafN. In this experiment, YafN couldn’t reverse the cell growth after inhibition by YafO. It seems to be difficult to control cell growth just like mazEF system, which demonstrated reverse of cell growth by antitoxin after function of toxin.
For more information, read BBa_K1949020, BBa_K1949030 !
mazFE Composite Parts: BBa_K1949100, BBa_K1949101, BBa_K1949102, BBa_K1949103 and BBa_K1949104
BBa_K1949100, BBa_K1949101 and BBa_K1949102 meets the Bronze Medal criteria!
BBa_K1949102 is our Best Composite Parts !
Stop & Go
The biggest attraction of the TA system is that it is able to control cell growth and synthesis of protein. In this experiment, mazE expression was induced by the addition of IPTG(2 mM) after mazE expression was induced by the addition of arabinose(0.02%). As a result, it was able to resuscitate from a state of being inhibited cell growth. We named this experiment as "Stop & Go" because it was to resuscitate growth from inhibiting cell growth.
It was found from Fig. 4-3-5 that MazF inhibited cell growth. MazE was induced 2 h after maze expression, and about 8 h later, cell growth was recovered that had stopped. From these results, it was suggested that E. coli whose cell growth was inhibited by MazF was able to resuscitate by expression of mazE.
For more information, read BBa_K1949100, BBa_K1949101 and BBa_K1949102.
Go & Stop
We found that a toxin inhibits cell growth, and an antitoxin resuscitates it. However, what will happen when a toxin is expressed after the antitoxin constitutive expression? Therefore, we conducted the experiment. Since cell growth was resuscitated after cells had grown, we named this experiment, "Go & Stop".
From Fig.4-3-6, E. coli encoded mazE which is on downstream of weak RBS(BBa_J61117) has more turbidity than E. coli encoded mazE which is on downstream of normal RBS(BBa_B0034). Both of those E. coli would reach stationary phase when there is little RFU of GFP(Fig. 4-3-6). E. coli encoded mazE which is on downstream of normal RBS reached almost the same stationary phase as E. coli without TA system.
For more information, BBa_K1949101, BBa_K1949102, BBa_K1949103 and BBa_K1949104.